Press Releases | Medtronic

Month Year

Email alerts

Apr 30, 2019

Medtronic Announces U.S. Commercial Launch of Solitaire(TM) X Revascularization Device

System Offers New Options for Improving Outcomes in Treating Stroke; World's Second-Leading Cause of Death, Third-Leading Cause of Disability

DUBLIN - April 30, 2019 - Medtronic plc (NYSE:MDT) today announced the U.S. launch of the Solitaire(TM) X Revascularization Device - and its first use in patients for the treatment of acute...
Apr 17, 2019

Medtronic VenaSeal(TM) Closure System Demonstrates Durable and Consistent Outcomes at Five Years in Patients with Chronic Venous Disease

(GLOBE NEWSWIRE via COMTEX) --DUBLIN and LONDON - April 17, 2019 - Medtronic plc (NYSE:MDT) today announced five-year outcomes from the VeClose Extension Study. Nick Morrison, M.D., Center for...
Apr 8, 2019

New Study Finds Targeted Drug Delivery (TDD) is Associated with a Reduction in Health Care Utilization and Cost for Cancer Pain Patients

Savings Are Driven by Fewer Inpatient Visits, Shorter Inpatient Length of Stay, and Fewer Emergency Department Visits

DUBLIN - April 8, 2019 - Medtronic plc (NYSE:MDT) today announced results of a study published in JAMA Network Open that demonstrates a reduction in health care utilization and cost for cancer...
Apr 8, 2019

New Value-Based Agreement Between Blue Cross and Blue Shield of Minnesota and Medtronic Leverages Diabetes Technology to Drive Positive Outcomes

Agreement Focuses on the Guardian Connect Smart CGM System, Improved Member Engagement and Measuring Time in Range

MINNEAPOLIS and DUBLIN - April 8, 2019 - Blue Cross and Blue Shield of Minnesota and Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, announce a new...
Apr 8, 2019

New Data Show Encouraging Economic Outcomes for Medtronic HeartWare(TM) HVAD(TM) System

Positive HVAD LATERALTM Study Results Also Now Published in The Journal of Heart and Lung Transplantation

DUBLIN and ORLANDO, Fla. - April 8, 2019 - Medtronic plc (NYSE:MDT) today announced data showing promising economic outcomes for the Medtronic HeartWare(TM) HVAD(TM) System after analyzing...
Apr 7, 2019

Medtronic Data Expands on Key Aortic Solutions for Challenging Anatomies

(GLOBE NEWSWIRE via COMTEX) --New EndoSuture Aneurysm Repair (ESAR) and Valiant Navion(TM) Data Presented at Charing Cross Demonstrate Safety and Efficacy in Patients with Complex Anatomies DUBLIN...
Apr 5, 2019

Medtronic HeartWare(TM) HVAD(TM) System Demonstrates Reduction in Total Strokes, Disabling Strokes and Stroke-Related Mortality with Blood Pressure Management

Company Has Initiated a Post-Approval Study of Heart Failure Management Best Practices to Further Demonstrate Improved Patient Outcomes

DUBLIN and ORLANDO, Fla. - April 5, 2019 - Medtronic plc (NYSE:MDT) today announced the results of an analysis on the impact of stroke severity in patients receiving its HeartWare(TM) HVAD(TM)...
Mar 17, 2019

New Clinical Trial Shows Medtronic TYRX(TM) Envelope Significantly Reduces Major Infections in Cardiac Implantable Device Patients

Late-Breaking Trial Results Presented at ACC Scientific Sessions and Published in The New England Journal of Medicine

DUBLIN and NEW ORLEANS - March 17, 2019 - Medtronic plc (NYSE:MDT) today announced results from the landmark Worldwide Randomized Antibiotic Envelope Infection Prevention Trial (WRAP-IT), which...
Mar 16, 2019

Medtronic Evolut Low Risk Trial Meets Primary Endpoint

Less Invasive Evolut™ Transcatheter Aortic Valve Replacement (TAVR) System Successful in Clinical Trial When Compared to Open Heart Surgery in Healthier Aortic Stenosis Patients

DUBLIN and NEW ORLEANS – March 16, 2019 – Medtronic plc (NYSE:MDT) today announced first-ever clinical data from the landmark Evolut Low Risk Trial comparing the minimally invasive Evolut™...
Mar 14, 2019

Medtronic Board Appoints Andrea J. Goldsmith, Ph.D. as a New Director

DUBLIN - March 14, 2019 - Medtronic plc (NYSE:MDT) today announced that its Board of Directors has appointed Andrea J. Goldsmith, Ph.D. to the Board as an independent director, effective March 11,...

Show per page